Acquisition boosts Symyx Research Services in Life Sciences and expands offering into Biologic Formulations

21-Aug-2008 - USA

Symyx Technologies, Inc. has announced the acquisition of Integrity Biosolution, LLC in an all-cash transaction. IntegrityBio offers contract formulation research and analytical services, providing formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.

The acquisition expands Symyx's Research Service offerings in life sciences into biologic formulations, complementing its existing chemical formulations services. According to the company, the combination of Symyx and IntegrityBio creates a differentiated set of large molecule formulation services to customers in the pharmaceutical and biotechnology industries by combining IntegrityBio's formulation expertise with Symyx's advanced high-throughput research and informatics capabilities.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance